Status:
COMPLETED
Safety of Autologous Cord Blood Cells for Preterm Infants.
Lead Sponsor:
Guangdong Women and Children Hospital
Conditions:
Safety Issues
Effect of Drugs
Eligibility:
All Genders
Up to 37 years
Phase:
EARLY_PHASE1
Brief Summary
To assess the safety of autologous volume- and red blood cell (RBC)-reduced non-cryopreserved umbilical cord blood (UCB) cell infusion to preterm infants.
Detailed Description
Preterm birth complications are one of the leading causes of death among children under 5 years of age. Despite advances in medical care, many survivors face a lifetime of disability, including mental...
Eligibility Criteria
Inclusion
- Inborn Infants admitted to the Neonatal Intensive Care Unit (NICU) of Guang Dong Women and Children's Hospital were eligible if they were: 1. Preterm: \<37 weeks gestation 2. Without congenital abnormalities; 3. Without maternal chorioamnionitis 4. had available UCB. 5.the mother was negative for hepatitis B (HBsAg and/or HBeAg) and C virus (anti-HCV), syphilis, HIV (anti-HIV-1 and -2) and IgM against cytomegalovirus, rubella, toxoplasma and herpes simplex virus.
Exclusion
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 5 2016
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT03760900
Start Date
January 1 2009
End Date
June 5 2016
Last Update
June 2 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.